Candida auris: Strategies and challenges for outbreaks prevention
Keywords:
Candida auris
Downloads
Download data is not yet available.
References
1. Meis JF, Chowdhary A. Candida auris: A global fungal public health threat. Lancet Infect Dis. 2018;18:1298-9. https://doi.org/10.1016/S1473-3099(18)30609-1
2. Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162-4. https://doi.org/10.3201/eid2301.161497
3. Parra-Giraldo CM, Valderrama SL, Cortes-Fraile G, Garzón JR, Ariza BE, Morio F, et al. First report of sporadic cases of Candida auris in Colombia. Int J Infect Dis. 2018;69:63-7. https://doi.org/10.1016/j.ijid.2018.01.034
4. Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis. 2019;68:15-21. https://doi.org/10.1093/cid/ciy411
5. Escandón P, Cáceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, et al. Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017. MMWR Morb Mortal Wkly Rep. 2018;67:459-60. https://doi.org/10.15585/mmwr.mm6715a6
6. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31. https://doi.org/10.1128/CMR.00029-17
7. Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90-1. https://doi.org/10.4103/0255-0857.108746
8. Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi (Basel). 2019;5. https://doi.org/10.3390/jof5040111
9. Centers for Disease Control and Prevention. Recommendations for identification of Candida auris. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/recommendations.html
10. Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallieres E, Munoz JF, Cuomo CA, et al. Identification of Candida auris using the updated 8.01 VITEK2 yeast identification system: A multilaboratory evaluation study. J Clin Microbiol. 2019;57. https://doi.org/10.1128/JCM.00884-19
11. Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: approved guideline. MM18-A. Wayne, PA: CLSI; 2008.
12. Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin Microbiol Newsl. 2017;39:99-103. https://doi.org/10.1016/j.clinmicnews.2017.06.003
13. Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T. Thinking beyond the common Candida species: need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris. J Clin Microbiol. 2017;55:3324-7. https://doi.org/10.1128/JCM.01355-17
14. Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green-based quantitative PCR assay. J Clin Microbiol. 2018;56. https://doi.org/10.1128/JCM.01337-18
15. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CL. J Clin Microbiol. 2015;53:1823-30. https://doi.org/10.1128/JCM.00367-15
16. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445-52. https://doi.org/10.1128/JCM.00630-17
17. Centers for Disease Control and Prevention. Antifungal susceptibility testing and interpretation. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candidaauris/c-auris-antifungal.html
18. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. https://doi.org/10.1186/s13756-016-0132-5
19. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrugresistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1234-7. https://doi.org/10.15585/mmwr.mm6544e1
20. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996-3005. https://doi.org/10.1128/JCM.00921-17
21. Centers for Disease Control and Prevention. Recommendations for infection prevention and control for Candida auris. 2018. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html
22. Newman E. Bleach wipes kill Candida auris. 2019. Fecha de consulta: 12 de febrero de 2020. Disponible en: https://www.mcknights.com/news/products/bleach-wipes-kill-candida-auris/
23. Dimond VJ. EPA approves diversey claim that oxiver 1 is effective against C. auris. 2019. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.hpnonline.com/evsfacility-services/article/21086724/epa-approves-diversey-claimthat-oxiver-1-is-e_ectiveagainst-c-auris
24. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50. https://doi.org/10.1093/cid/civ933
2. Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, Martínez HP, Rodríguez GJ, Álvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162-4. https://doi.org/10.3201/eid2301.161497
3. Parra-Giraldo CM, Valderrama SL, Cortes-Fraile G, Garzón JR, Ariza BE, Morio F, et al. First report of sporadic cases of Candida auris in Colombia. Int J Infect Dis. 2018;69:63-7. https://doi.org/10.1016/j.ijid.2018.01.034
4. Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis. 2019;68:15-21. https://doi.org/10.1093/cid/ciy411
5. Escandón P, Cáceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, et al. Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017. MMWR Morb Mortal Wkly Rep. 2018;67:459-60. https://doi.org/10.15585/mmwr.mm6715a6
6. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31. https://doi.org/10.1128/CMR.00029-17
7. Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90-1. https://doi.org/10.4103/0255-0857.108746
8. Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi (Basel). 2019;5. https://doi.org/10.3390/jof5040111
9. Centers for Disease Control and Prevention. Recommendations for identification of Candida auris. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/recommendations.html
10. Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallieres E, Munoz JF, Cuomo CA, et al. Identification of Candida auris using the updated 8.01 VITEK2 yeast identification system: A multilaboratory evaluation study. J Clin Microbiol. 2019;57. https://doi.org/10.1128/JCM.00884-19
11. Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: approved guideline. MM18-A. Wayne, PA: CLSI; 2008.
12. Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin Microbiol Newsl. 2017;39:99-103. https://doi.org/10.1016/j.clinmicnews.2017.06.003
13. Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T. Thinking beyond the common Candida species: need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris. J Clin Microbiol. 2017;55:3324-7. https://doi.org/10.1128/JCM.01355-17
14. Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green-based quantitative PCR assay. J Clin Microbiol. 2018;56. https://doi.org/10.1128/JCM.01337-18
15. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CL. J Clin Microbiol. 2015;53:1823-30. https://doi.org/10.1128/JCM.00367-15
16. Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445-52. https://doi.org/10.1128/JCM.00630-17
17. Centers for Disease Control and Prevention. Antifungal susceptibility testing and interpretation. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candidaauris/c-auris-antifungal.html
18. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. https://doi.org/10.1186/s13756-016-0132-5
19. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrugresistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1234-7. https://doi.org/10.15585/mmwr.mm6544e1
20. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996-3005. https://doi.org/10.1128/JCM.00921-17
21. Centers for Disease Control and Prevention. Recommendations for infection prevention and control for Candida auris. 2018. Fecha de consulta: 13 de febrero de 2020. Disponible en: https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html
22. Newman E. Bleach wipes kill Candida auris. 2019. Fecha de consulta: 12 de febrero de 2020. Disponible en: https://www.mcknights.com/news/products/bleach-wipes-kill-candida-auris/
23. Dimond VJ. EPA approves diversey claim that oxiver 1 is effective against C. auris. 2019. Fecha de consulta: 8 de febrero de 2020. Disponible en: https://www.hpnonline.com/evsfacility-services/article/21086724/epa-approves-diversey-claimthat-oxiver-1-is-e_ectiveagainst-c-auris
24. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50. https://doi.org/10.1093/cid/civ933
How to Cite
1.
Zuluaga-Rodríguez A. Candida auris: Strategies and challenges for outbreaks prevention. Biomed. [Internet]. 2020 Mar. 1 [cited 2026 Mar. 13];40(1):5-10. Available from: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/5454
Some similar items:
- Catalina de Bedout, Julio Ayabaca, Ricardo Vega, Matilde Méndez, Axel R. Santiago, María Lucrecia Pabón, Angela Tabares, Myrtha Arango, Angela Restrepo, Vance Newell, Evaluation of Candida species' susceptibility to fluconazole with the disk diffusion method. , Biomedica: Vol. 23 No. 1 (2003)
- Matilde Anaya, Eduardo Barbará, Jesús Padrón, Sofía F. Borrego, Oderlaise Valdés, Alian Molina, Influence of magnetic field on the growth of pathogen microorganisms isolated from the indoor environment at the Archivo Nacional de la República de Cuba , Biomedica: Vol. 35 No. 3 (2015)
- Javier Araiza , Valentín Sánchez-Pedraza, Ana Karen Carrillo , Denise Fernández-Samar, Jazmín Tejeda, Alexandro Bonifaz, Mixed oral candidiasis in type 2 diabetic patients: Identification and spectrum of sensitivity , Biomedica: Vol. 43 No. Sp. 1 (2023): Agosto, Micología médica
- Martha Puello, Gregorio Young, Paola Suárez, Phospholipase and proteinase activities of isolates of colonizing Candida spp. causing vulvovaginitis in pregnant women , Biomedica: Vol. 43 No. Sp. 1 (2023): Agosto, Micología médica
- Paola Marsela Pérez-Camacho, Carmen Vargas-Moran, Laura Torres-Canchala , Camila Ariza-Insignares , Lina M. Sandoval-Calle , Inés Elvira Gómez-Hernández , Paula Solís-Núñez, Juliana V. Cedeño-Castaño, Ana M. Aguilar-González, Jaime Alberto Patiño-Niño, Epidemiological characteristics of pediatric patients with invasive candidiasis in an intensive care unit in southwestern Colombia , Biomedica: Vol. 45 No. 1 (2025)
Published
2020-03-01
Issue
Section
Editorial
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
Escanea para compartir
